Back
Viking Therapeutics, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
43
VKTX
Viking Therapeutics, Inc.
Last Price:
$34.32
Seasonality Move:
23.23%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atViking Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically risen by 57.2% based on the past 10 years of stock performance.
-
Viking Therapeutics, Inc. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Viking Therapeutics, Inc. Stock Undervalued?The current Viking Therapeutics, Inc. [VKTX] share price is $34.34. The Score for VKTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically risen by 57.2% based on the past 10 years of stock performance.
Viking Therapeutics, Inc. Stock Rating
Sell
43
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. overpriced?
-
Viking Therapeutics, Inc. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Viking Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
43.15
52-Week Low:
18.92
Prediction Charts
Market Cap:
3.9B
Price in USD:
34.34
Volume:
6.9M
Beta:
1.33
Technical Analysis
SMA50:
35.83
SMA100:
32.57
SMA200:
30.63
52-Wk Change:
1.21%
Stock Predictions
-
Is Viking Therapeutics, Inc. stock public?Yes, Viking Therapeutics, Inc. is a publicly traded company.
-
What is the Viking Therapeutics, Inc. stock quote today?The Viking Therapeutics, Inc. stock price is 34.34 USD today.
-
How to buy Viking Therapeutics, Inc. stock online?You can buy Viking Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-24 | 36.68 | 37.35 | 37.83 | 36.22 |
| Dec-26 | 37.25 | 37.18 | 37.44 | 36.00 |
| Dec-29 | 36.74 | 36.46 | 37.09 | 36.13 |
| Dec-30 | 36.46 | 35.32 | 36.66 | 35.21 |
| Dec-31 | 35.14 | 35.18 | 35.50 | 34.67 |
| Jan-2 | 35.54 | 35.42 | 36.17 | 34.88 |
| Jan-5 | 35.20 | 32.14 | 35.21 | 31.85 |
| Jan-6 | 31.88 | 32.30 | 33.28 | 31.56 |
| Jan-7 | 32.50 | 32.38 | 33.35 | 31.73 |
| Jan-8 | 32.30 | 31.65 | 32.30 | 31.59 |
| Jan-9 | 32.35 | 31.99 | 32.94 | 31.79 |
| Jan-12 | 32.33 | 31.76 | 32.33 | 31.04 |
| Jan-13 | 31.69 | 30.69 | 31.82 | 29.54 |
| Jan-14 | 30.69 | 34.34 | 36.00 | 30.56 |
Viking Therapeutics, Inc. Earnings
Viking Therapeutics, Inc. Earnings Report: Per Share Viking Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics, Inc. Forecast Revenue Growth
Viking Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.28 per share.
* Viking Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.